Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2014
Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survivalLaura Spring, Shuli Li, Robert J Soiffer, et al.
Transplantation|July 23, 2002
Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantationThomas S Lin, David Zahrieh, Edie Weller, et al.
The Oncologist|May 7, 2014
Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimensNandita Khera, Amy Emmert, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall SurvivalJennifer Crombie, Laura Spring, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationEdwin P Alyea, Shuli Li, Haesook T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cellsEmmanuel Zorn, Kathy S Wang, Ephraim P Hochberg, et al.
European Journal of Heart Failure|May 10, 2017
Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemiaDavid D Berg, Muthiah Vaduganathan, Anju Nohria, et al.
Heartrhythm Case Reports|July 1, 2021
High-grade heart block associated with ibrutinib therapyAlexander R Vartanov, Benjamin L Lampson, Eric D Jacobsen, et al.
Blood|September 28, 2002
Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costsStephanie J Lee, David Zahrieh, Edwin P Alyea, et al.
Journal of Oncology Practice|August 15, 2013
Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical centerBrett E Glotzbecker, Deborah S Yolin-Raley, Daniel J DeAngelo, et al.
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2014
Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survivalLaura Spring, Shuli Li, Robert J Soiffer, et al.
Transplantation|July 23, 2002
Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantationThomas S Lin, David Zahrieh, Edie Weller, et al.
The Oncologist|May 7, 2014
Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimensNandita Khera, Amy Emmert, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall SurvivalJennifer Crombie, Laura Spring, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationEdwin P Alyea, Shuli Li, Haesook T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cellsEmmanuel Zorn, Kathy S Wang, Ephraim P Hochberg, et al.
European Journal of Heart Failure|May 10, 2017
Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemiaDavid D Berg, Muthiah Vaduganathan, Anju Nohria, et al.
Heartrhythm Case Reports|July 1, 2021
High-grade heart block associated with ibrutinib therapyAlexander R Vartanov, Benjamin L Lampson, Eric D Jacobsen, et al.
Blood|September 28, 2002
Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costsStephanie J Lee, David Zahrieh, Edwin P Alyea, et al.
Journal of Oncology Practice|August 15, 2013
Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical centerBrett E Glotzbecker, Deborah S Yolin-Raley, Daniel J DeAngelo, et al.
Pageof 18